Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Cash Flows

v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
May 31, 2025
May 31, 2024
May 31, 2023
Operating activities      
Net income $ 1,657.3 $ 1,690.4 $ 1,557.3
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 209.5 176.5 176.6
Amortization of premiums and discounts on AFS securities, net 23.4 (7.0) 18.2
Amortization of deferred contract costs 236.5 231.7 219.1
Stock-based compensation costs 111.8 61.1 62.6
Benefit from deferred income taxes (15.8) (29.8) (44.0)
Provision for credit losses 24.2 19.8 17.7
Net realized losses on sales of AFS securities 0.4 2.6 9.8
Net realized losses on disposal of assets 3.7 32.8 1.3
Premium paid on cash flow hedges (19.2) 0.0 0.0
Changes in operating assets and liabilities:      
Interest receivable (3.8) 1.1 (2.1)
Accounts receivable and PEO unbilled receivables, net (130.7) 113.0 (135.7)
Prepaid expenses and other current assets (12.0) (25.2) (17.8)
Accounts payable and other current liabilities 42.3 (127.0) 86.3
Deferred costs (246.5) (244.9) (269.4)
Net change in other long-term assets and liabilities 21.9 6.1 30.6
Net change in operating lease right-of-use assets and liabilities (2.1) (3.5) (4.3)
Net cash provided by operating activities 1,900.9 1,897.7 1,706.2
Investing activities      
Purchases of AFS securities (14,302.9) (6,868.5) (14,585.3)
Proceeds from sales and maturities of AFS securities 14,292.5 7,161.2 14,943.2
Net change in purchased receivables (157.3) (153.8) (6.8)
Purchases of property and equipment (191.8) (161.4) (143.0)
Proceeds from sales of property and equipment 0.0 0.0 16.7
Acquisition of businesses, net of cash acquired (2,967.5) (208.3) (2.7)
Purchases of other assets (29.8) (30.1) (10.4)
Net cash (used in)/provided by investing activities (3,356.8) (260.9) 211.7
Financing activities      
Net change in client fund obligations (290.7) (425.3) 474.8
Net proceeds from short-term borrowings 0.0 9.0 2.0
Proceeds from issuance of corporate bonds 4,180.9 0.0 0.0
Dividends paid (1,448.5) (1,315.3) (1,175.0)
Repurchases of common shares (104.5) (169.2) 0.0
Debt issuance costs (47.8) 0.0 0.0
Contingent consideration paid for acquisitions 0.0 0.0 (2.8)
Activity related to equity-based plans 3.8 26.1 (10.4)
Net cash provided by/(used in) financing activities 2,293.2 (1,874.7) (711.4)
Net change in cash, restricted cash, and equivalents 837.3 (237.9) 1,206.5
Cash, restricted cash, and equivalents, beginning of fiscal year 1,897.0 2,134.9 928.4
Cash, restricted cash, and equivalents, end of fiscal year 2,734.3 1,897.0 2,134.9
Reconciliation of cash, restricted cash, and equivalents      
Cash and cash equivalents 1,628.6 1,468.9 1,222.0
Restricted cash 47.9 47.8 49.8
Restricted cash and restricted cash equivalents included in funds held for clients 1,057.8 380.3 863.1
Total cash, restricted cash, and equivalents $ 2,734.3 $ 1,897.0 $ 2,134.9